| Identification | Back Directory | [Name]
L-Glutamine, L-methionyl-L-threonyl-L-α-glutamyl-L-tyrosyl-L-lysyl-L-leucyl-L-valyl-L-valyl-L-valylglycyl-L-alanylglycyl-L-α-aspartyl-L-valylglycyl-L-lysyl-L-seryl-L-alanyl-L-leucyl-L-threonyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-isoleucyl- (9CI) | [CAS]
145019-94-9 | [Synonyms]
KRAS G13D peptide, 25 mer
L-Glutamine, L-methionyl-L-threonyl-L-α-glutamyl-L-tyrosyl-L-lysyl-L-leucyl-L-valyl-L-valyl-L-valylglycyl-L-alanylglycyl-L-α-aspartyl-L-valylglycyl-L-lysyl-L-seryl-L-alanyl-L-leucyl-L-threonyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-isoleucyl- (9CI) | [Molecular Formula]
C118H201N29O36S | [MOL File]
145019-94-9.mol | [Molecular Weight]
2634.13 |
| Chemical Properties | Back Directory | [Boiling point ]
2477.0±65.0 °C(Predicted) | [density ]
1.257±0.06 g/cm3(Predicted) | [Sequence]
Met-Thr-Glu-Tyr-Lys-Leu-Val-Val-Val-Gly-Ala-Gly-Asp-Val-Gly-Lys-Ser-Ala-Leu-Thr-Ile-Gln-Leu-Ile-Gln |
| Hazard Information | Back Directory | [Uses]
KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1]. | [References]
[1] Huang EYC, et, al. Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides. WO2018144775A1. |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|